Vito Terlizzi

Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients

Antonietta Lambiase, Maria Rosaria Catania, Mariassunta Del Pezzo et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2011 · 145 citations · Full text

Antimicrobial Susceptibility, Antibiotics, Body Mass Index +12

Genotype–phenotype correlation and functional studies in patients with cystic fibrosis bearing CFTR complex alleles

Vito Terlizzi, Giuseppe Castaldo, Donatello Salvatore et al. · Journal of Medical Genetics · 2016 · 67 citations · Full text

Hyaluronic acid improves “pleasantness” and tolerability of nebulized hypertonic saline in a cohort of patients with cystic fibrosis

Paolo Buonpensiero, Fabiola De Gregorio, Angela Sepe et al. · Advances in Therapy · 2010 · 66 citations

Hyaluronic Acid, Physiology, Medicine +2

Elexacaftor/Tezacaftor/Ivacaftor in Patients with Cystic Fibrosis Homozygous for the F508del Mutation and Advanced Lung Disease: A 48-Week Observational Study

Vincenzo Carnovale, Paola Iacotucci, Vito Terlizzi et al. · Journal of Clinical Medicine · 2022 · 56 citations · Full text

A survey of the prevalence, management and outcome of infants with an inconclusive diagnosis following newborn bloodspot screening for cystic fibrosis (CRMS/CFSPID) in six Italian centres

Vito Terlizzi, Laura Claut, Antonella Tosco et al. · Journal of Cystic Fibrosis · 2021 · 50 citations · Full text

Italian Centres, Newborn Bloodspot, Clinical Epidemiology +2